Orlibes Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Orlistat

Indications/Uses

In conjunction w/ mildly hypocaloric diet for the treatment of obese patients w/ BMI ≥30 kg/m² or those overwt w/ BMI >28 kg/m² w/ risk factors.

Dosage/Direction for Use

Adult 120 mg.

Administration

Should be taken with food: Take w/ meals or 1 hr after meals.

Contraindications

Hypersensitivity. Patients w/ chronic malabsorption, cholestasis. Lactation.

Special Precautions

May increase the possibility of GI disturbances if orlistat is taken w/ high fat diet. Type 2 DM. May reduce the absorption of fat-soluble vit (A, D, E, K). Pregnancy & lactation.

Adverse Reactions

Oily spotting, flatus w/ fecal discharge, fecal urgency, fatty/oily stools, increased defecation, fecal incontinence. Abdominal discomfort, flatulence, diarrhea, soft stool, tooth or gum effects. Upper or lower resp tract infections, flu, headache, menstrual disorders, anxiety, fatigue, UTI.

View ADR Monitoring Form

Drug Interactions

Enhanced bioavailability & lipid-lowering effect of pravastatin. Reduce the absorption of vit D, E, β-carotene. Fibrate, acarbose, biguanide, anorectic agents. Warfarin or other anticoagulants. Oral hypoglycaemic drugs eg, sulfonylurea.

MIMS Class

Anti-Obesity Agents

ATC Classification

A08AB01 - orlistat ; Belongs to the class of peripherally acting antiobesity products.

Regulatory Classification

Presentation/Packing

Form

Orlibes cap 120 mg

Packing/Price

3 × 10's

Orlibes

orlistat

Manufacturer:

Meprofarm